急性心肌梗死后心脏破裂的治疗经验
该回顾性研究纳入2015年6月至2017年6月南京大学附属鼓楼医院收治的6例急性心肌梗死后心脏破裂患者,分析其临床特点、治疗方法及疗效。结果显示,接受外科手术治疗的3例患者均康复出院,而保守治疗的3例中院内死亡2例、自动出院1例;结论认为在血管活性药物和IABP辅助基础上,外科手术是可行选择,ECMO可能改善围手术期状态。
要点
- 6例患者心功能均为Killip Ⅱ级,梗死部位以广泛前壁(3例)和前壁(2例)为主。
- 心脏破裂类型包括室间隔穿孔4例、乳头肌断裂1例、左心室游离壁破裂1例。
- 外科手术治疗的3例均康复出院,保守治疗的3例中2例院内死亡。
核心结论
- 在血管活性药物和IABP辅助基础上,外科手术可治疗急性心肌梗死后心脏破裂。
- ECMO的应用可能优化此类患者的围手术期情况。
研究设计与样本
- 回顾性研究,纳入2015年6月至2017年6月在南京大学附属鼓楼医院治疗的急性心肌梗死后心脏破裂患者6例。
- 分析其临床特点、治疗方法和疗效。
主要发现
- 入院时所有患者心功能Killip分级均为Ⅱ级。
- 广泛前壁心肌梗死3例,前壁心肌梗死2例,下壁心肌梗死1例。
- 室间隔穿孔4例,乳头肌断裂1例,左心室游离壁破裂1例。
- 接受手术治疗的3例患者均顺利康复出院。
- 采用保守治疗的3例患者中,院内死亡2例,自动出院1例。
临床怎么用
- 所有患者均持续泵入血管活性药物并应用IABP。
- 1例未手术患者和1例手术患者应用了ECMO、机械通气和CRRT。
- 接受手术治疗的3例中,术后1例继续应用IABP,1例继续应用ECMO、IABP和CRRT,1例未应用IABP或ECMO。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the treatment results of cardiac rupture in patients with acute myocardial infarction (AMI) . Method: Clinical data of 6 with cardiac rupture after AMI, who were hospitalized in our hospital from June 2015 to June 2017, were retrospectively analyzed,and the clinical manifestations, methods of treatment and outcomes were investigated. Results: Cardiac function classification was Killip class Ⅱin all patients. There were 3 massive anterior wall myocardial infarction, 2 anterior wall myocardial infarction,and 1 inferior myocardial infarction. There were 4 patients with ventricular septal defect, 1 patient with rupture of papillary muscle,and 1 patient with left ventricular free wall rupture.All patients received continuous infusion of vasoactive medicines and treated with intra-aortic balloon pump(IABP), 2 patients (1 patient accepted operative treatment,and 1 patient received conservative treatment) were treated with extracorporeal membrane oxygenation (ECMO), mechanical ventilation,and continuous renal replacement therapy(CRRT).Three patients received surgical repair,1 case was supported by IABP, 1 case supported by ECMO,CRRT,and IABP,and 1 case did not use IABP or ECMO post operation. All 3 surgically treated patients recovered successfully and were discharged from hospital.Meanwhile, in the other 3 patients treated conservatively, 2 patients died in the hospital and 1 patient was discharged according to own will. Conclusion: On the basis of vasoactive medicines and IABP, surgery repair is a feasible option for cardiac rupture patients secondary to AMI,and ECMO may improve the perioperative state in these patients. 目的: 总结救治急性心肌梗死后心脏破裂的经验。 方法: 采用回顾性研究方法,纳入2015年6月至2017年6月在南京大学附属鼓楼医院治疗的急性心肌梗死后心脏破裂患者6例,分析其临床特点、治疗方法和疗效。 结果: 入院时,所有急性心肌梗死后心脏破裂患者的心功能(Killip分级)均为Ⅱ级。其中,广泛前壁心肌梗死3例,前壁心肌梗死2例,下壁心肌梗死1例;室间隔穿孔4例,乳头肌断裂1例,左心室游离壁破裂1例。患者均持续泵入血管活性药物,并应用主动脉内球囊反搏(IABP)。在此基础上,各有1例未手术患者和手术患者应用体外膜肺氧合(ECMO)、机械通气和连续肾脏替代治疗(CRRT)。接受手术治疗患者共3例,术后1例患者继续应用IABP,1例患者继续应用ECMO、IABP和CRRT,1例患者未应用IABP或ECMO。接受手术治疗的3例患者均顺利康复出院;采用保守治疗的3例患者中,院内死亡2例,自动出院1例。 结论: 在血管活性药物和IABP辅助的基础上,外科手术可治疗急性心肌梗死后心脏破裂,而ECMO的应用可以优化围手术期情况。.
引用
- Ye JX, Ge M, Wang DJ, et al. [Treatment experience of cardiac rupture in patients with acute myocardial infarction]. Zhonghua Xin Xue Guan Bing Za Zhi. 2018. PMID: 30032547. doi:10.3760/cma.j.issn.0253-3758.2018.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。